[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019 Herpes Zoster (Shingles) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 175 pages | ID: 21585A3C801EN
VPAResearch

US$ 1,619.00 US$ 1,799.00 -10 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global clinical trial report- “2019 Herpes Zoster (Shingles) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Herpes Zoster (Shingles). It presents in-depth analysis of Herpes Zoster (Shingles) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Herpes Zoster (Shingles).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Herpes Zoster (Shingles) clinical trials by-
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Herpes Zoster (Shingles)

The research work is prepared through extensive and continuous research on Herpes Zoster (Shingles) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Herpes Zoster (Shingles) patients are identified
  • The report includes panorama of Herpes Zoster (Shingles) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Herpes Zoster (Shingles) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Herpes Zoster (Shingles) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Herpes Zoster (Shingles) Clinical Trials by Region
  2.2.2 Average Enrollment of Herpes Zoster (Shingles) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Herpes Zoster (Shingles) Treatment, 2019

3. REGION WISE HERPES ZOSTER (SHINGLES) CLINICAL TRIALS

3.1 Asia Pacific Herpes Zoster (Shingles) Clinical Trials by Country
3.2 Europe Herpes Zoster (Shingles) Clinical Trials by Country
3.3 North America Herpes Zoster (Shingles) Clinical Trials by Country
3.4 Middle East and Africa Herpes Zoster (Shingles) Clinical Trials by Country
3.5 South and Central America Herpes Zoster (Shingles) Clinical Trials by Country

4. HERPES ZOSTER (SHINGLES) CLINICAL TRIAL TRENDS

4.1 Start Year wise Herpes Zoster (Shingles) Clinical Trials
4.2 Phase wise Herpes Zoster (Shingles) Clinical Trials
4.3 Trial Status wise Herpes Zoster (Shingles) Clinical Trials
4.4 Trial Type wise Herpes Zoster (Shingles) Clinical Trials

5. HERPES ZOSTER (SHINGLES) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Herpes Zoster (Shingles) Trials by Year
5.2 Average Enrollment in Herpes Zoster (Shingles) Trials by Phase
5.3 Average Enrollment in Herpes Zoster (Shingles) Trials by Status
5.4 Average Enrollment in Herpes Zoster (Shingles) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN HERPES ZOSTER (SHINGLES) CLINICAL TRIALS

6.1 Herpes Zoster (Shingles) Trials by Sponsor Type
6.2 Herpes Zoster (Shingles) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Herpes Zoster (Shingles) Trials- Phase
7.2 Herpes Zoster (Shingles) Trials- Phase
7.3 Herpes Zoster (Shingles) Trials- Phase
7.4 Herpes Zoster (Shingles) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

LIST OF FIGURES

Figure 1: Herpes Zoster (Shingles) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Figure 7: North America – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Figure 9: Herpes Zoster (Shingles) Clinical Trials by Phase
Figure 10: Herpes Zoster (Shingles) Clinical Trials by Trial Status
Figure 11: Herpes Zoster (Shingles) Clinical Trials by Type
Figure 12: Herpes Zoster (Shingles) Clinical Trials by Sponsor Type
Figure 13: Herpes Zoster (Shingles) Clinical Trials by Leading Sponsors
Figure 14: Herpes Zoster (Shingles) Average Enrollment by Phase
Figure 15: Herpes Zoster (Shingles) Average Enrollment by Trial Status
Figure 16: Herpes Zoster (Shingles) Average Enrollment by Type
Figure 17: Herpes Zoster (Shingles)- Average Enrolment by Type of Sponsors
Figure 18: Herpes Zoster (Shingles)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

LIST OF TABLES

Table 1: Herpes Zoster (Shingles) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Table 5: Europe – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Table 7: North America – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Herpes Zoster (Shingles) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Herpes Zoster (Shingles) Average Enrollment by Phase
Table 15: Herpes Zoster (Shingles) Average Enrollment by Trial Status
Table 16: Herpes Zoster (Shingles) Average Enrollment by Type
Table 17: Herpes Zoster (Shingles)- Average Enrolment by Type of Sponsors
Table 18: Herpes Zoster (Shingles)- Enrolment by Leading Sponsors


More Publications